ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1746

Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis

Brigitte Michelsen1, Andreas P Diamantopoulos1,2, Hilde Berner Hammer3, Dag Magnar Soldal4, Arthur Kavanaugh5 and Glenn Haugeberg1,6,7, 1Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 2Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology, Hospital of Southern Norway, Kristiansand, Norway, 5University of California, San Diego School of Medicine, LaJolla, CA, 6Rheumatology, Martina Hansens Hospital, Gjettum, Norway, 7Rheumatology, The Norwegian University of Science and Technology, Trondheim, Norway

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: patient outcomes, psoriatic arthritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Comorbidities and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Coping may be defined as the set of adaptive processes a patient uses to live well with aspects of disease such as pain. Coping may represent an ability to help manage symptoms in patients with arthritides. This study aimed to explore the influence of patient’s ability to cope on patient reported outcome measures (PROs) and composite clinical scores in psoriatic arthritis (PsA), and to determine whether differential ability to cope influences the association between clinical and ultrasonographic (US) findings in PsA.

Methods: In this cross sectional study 141 PsA patients were consecutively recruited from an out-patient clinic. They all fulfilled the CASPAR criteria for PsA. 66 swollen/68 tender joint count (SJC/TJC), PROs and composite scores were registered. US evaluation of 34 joints and additionally joints found to be swollen/tender by 66/68 joint count, 15 tendons, 10 entheses and additionally entheses found to be tender by clinical examination of 19 other entheses was performed. Patients reported their level of coping on a visual analogue scale (VAS, range 0-100 mm, 100 mm worst coping). Gray scale (GS) and power Doppler (PD) sum scores of joints, entheses and tendons were assessed. Correlation analyses were performed by Spearman’s rank correlation test (non-parametric distribution of the data). To explore the relation between patient’s ability of coping, clinical factors and composite scores we used multiple regression analyses.

Results: We found that coping was strongly correlated (p<0.001) to joint pain (r=0.67), patient global assessment (PGA) (r=0.73) and TJC68 (r=0.42). When separating into good (116 patients) and poor (24 patients) ability of coping (defined as ≤50 and >50 mm on a VAS scale, respectively), we found that patients with poor ability of coping had no correlations between several PROs and composite scores, whereas patients with good ability of coping had weak to moderate correlations (table). Patients with poor ability of coping had on average higher Disease Activity Index for Psoriatic Arthritis (DAPSA) (20.0±2.5, p<0.001), Composite Psoriasis Disease Activity Index (CPDAI) (2.8±0.5, p<0.001 ), Psoriatic ArthritiS Disease Activity Score (PASDAS) (0.27±0.1, p=0.006) score, Disease Activity Score 28 (DAS28) (1.1±0.2, p<0.001) and Simple Disease Activity Index (SDAI) (10,7±1.3, p<0.001), model adjusted for age, gender and PD sum score.

 

Good coping

Poor coping

Good coping

Poor coping

GS total

PD total

GS total

PD total

GS joints

PD joints

GS joints

PD joints

TJC 68

NS

NS

NS

NS

NS

NS

NS

NS

SJC 66

 0,18*

  0,31**

NS

NS

0,27**

0,46***

NS

NS

PGA

NS

0,19*

NS

NS

NS

NS

NS

NS

DAPSA

NS

0,23*

NS

NS

NS

0,23*

NS

NS

 DAS28

0,23*

 0,27**

NS

NS

NS

0,33***

NS

NS

SDAI

0,23*

 0,26**

NS

NS

NS

0,30**

NS

NS

Spearman’s rank correlation test, *p<0.05, **p<0.01, ***p<0.001

Conclusion: Patient’s ability of coping is influencing PROs in PsA. US evaluation of disease activity is correlated to clinical findings for patients with good ability of coping, but not for patients with poor ability of coping.


Disclosure: B. Michelsen, None; A. P. Diamantopoulos, None; H. B. Hammer, None; D. M. Soldal, None; A. Kavanaugh, None; G. Haugeberg, Pfizer Norway, 2.

To cite this abstract in AMA style:

Michelsen B, Diamantopoulos AP, Hammer HB, Soldal DM, Kavanaugh A, Haugeberg G. Patient’s Ability of Coping Is Influencing the Correlation Between Clinical and Ultrasonographic Evidence of Disease Activity in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/patients-ability-of-coping-is-influencing-the-correlation-between-clinical-and-ultrasonographic-evidence-of-disease-activity-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-ability-of-coping-is-influencing-the-correlation-between-clinical-and-ultrasonographic-evidence-of-disease-activity-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology